340B Drug Pricing Program
The House Energy and Commerce Subcommittee on Health is expected to hold a follow-up hearing on transparency and competition in health care. The AHA appreciates your outreach in advance of the March 28 hearing; however, based on the comments representatives made during the recent hearing, it is…
Discover how the ASAP 340B coalition's policy proposals contradict Congress' intent to preserve the 340B program. Patients' lives are at stake.
Ensuring the Protection of the Vital 340B Program for Patients and Providers
Once again, the Pharmaceutical Research and Manufacturers of America (PhRMA) has demonstrated its willingness to put the profits of its drug company members over the needs of America’s patients.
AHA Statement before the House Committee on Energy and Commerce Subcommittee on Health regarding Lowering Unaffordable Costs: Examining Transparency and Competition in Health Care.
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other groups to remove many hospitals, eligible drugs and patients from the 340B program “would only…
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other groups to remove many hospitals, eligible drugs and patients from the 340B program “would only…
Hospital and pharmacist advocates for safety-net health care and affordable prescription drugs are united in their firm opposition to a misguided effort by the drug industry and some community health centers that would restrict access to the 340B drug pricing program.
The AHA will continue to fight to protect the 340B program and the patients it benefits against unfounded attacks by big drug companies.
AHA slams group’s proposal that would hurt 340B Program
The AHA today responded to a new group that includes the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other organizations calling for legislative changes that would hurt the 340B…